Mar 26, 2015 at 22:25 | Source: CNBC-TV18
The leather footwear industry in Chennai seems all set to take some big strides. With the Budget reducing excise duty on leather shoes, manufacturers who were catering primarily to export markets, are now gearing up to take advantage of the big local opportunity. Jude Sannith gets us this report from Tamil Nadu's leather hub, Ranipet.
Mar 25, 2015 at 21:00 | Source: PTI
Glenmark's medicines, Zita and Zita-Met, cost 30 percent less than MSD's Januvia and Janumet, which is due to the customs duty paid by the US firm, the High Court had said and added that "no allegation has been made that MSD on Wednesday sells its drugs at a relatively high price that hinders access to the drug".
Mar 25, 2015 at 11:09 | Source: Moneycontrol.com
Ipca Laboratories has informed that the US FDA has issued import alert to its two formulations manufacturing units situated at SEZ Indore (Pithampur) and Piparia (Silvassa) on March 24, 2015.
Mar 20, 2015 at 10:45 | Source: Moneycontrol.com
According to Angel Broking, Rupee will likely appreciate today owing to weakness in the DX following weak employment and manufacturing data from the US. However, state-run banks buying dollars on behalf of RBI will restrict sharp gains.
Mar 19, 2015 at 12:04 | Source: Moneycontrol.com
Shares of Wockhardt rallied 5.4 percent intraday Thursday after the US health regulator has not found any issues at Chikalthana plant.
Mar 18, 2015 at 19:05 | Source: PTI
Drug maker Wockhardt on Wednesday said the US health regulator has not found any issues with respect to data security and control measures at Chikalthana plant in a recent inspection.
Mar 11, 2015 at 12:00 | Source: Moneycontrol.com
Investors lapped up more shares of Shilpa Medicare on Wednesday after the US Food and Drug Administration (US FDA) has inspected 2 manufacturing units at Raichur. The stock hit a life high of Rs 1,018.50, up 10 percent intraday.
Mar 04, 2015 at 12:00 | Source: Moneycontrol.com
Sun Pharma topped the buying list on Sensex, up 6 percent. Even its subsidiary Sun Pharma Advanced Research Company gained 6 percent on getting US FDA nod for Elepsia XR extended release tablets, an anti-epileptic drug. SPARC says product will be manufactured by Sun Pharma at Halol unit.
Feb 23, 2015 at 15:17 | Source: Reuters
The FDA inspected the plant in January this year, after which it issued the company a so-called Form 483, listing six observations on the manufacturing processes at the plant, Lupin said in a statement, without giving details.
Feb 23, 2015 at 11:08 | Source: Moneycontrol.com
According to Angel Broking, Indian Rupee is expected likely to depreciate today owing to strength in the DX following robust manufacturing data from the US. Also, month-end dollar demand from importers will keep the rupee under pressure and will act as a negative factor.